{"id":8725,"date":"2013-11-12T03:19:18","date_gmt":"2013-11-12T08:19:18","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=8725"},"modified":"2013-11-12T03:19:18","modified_gmt":"2013-11-12T08:19:18","slug":"european-stocks-advance","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/","title":{"rendered":"European stocks advance"},"content":{"rendered":"<p>The FTSE 100 is testing its new support level at 6700. Follow-through above 6800 would indicate respect &mdash; and an advance to the December 1999 high of 6950\/7000*. Rising 13-week Twiggs Money Flow suggests buying pressure. Reversal below 6600 is unlikely, but would warn of a correction to primary support at 6400.<\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" width=\"525\" height=\"355\" title=\"FTSE 100\" alt=\"FTSE 100\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png?resize=525%2C355&#038;ssl=1\" \/><\/p>\n<p style=\"text-align:right;font-size:.9em;color:#999999;\">* Target calculation: 6700 + ( 6700 &#8211; 6400 ) = 7000<\/p>\n<p>Dow Jones Euro Stoxx 50 is testing support at its 2009\/2011 high of 3000. Rising 13-week Twiggs Momentum suggests a primary up-trend. Respect of support at 3000 is likely and follow-through above 3100 would confirm an advance to 3500*.<\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter\" width=\"525\" height=\"355\" title=\"Euro Stoxx 50\" alt=\"Euro Stoxx 50\" src=\"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-12-stoxx.png?resize=525%2C355&#038;ssl=1\" \/><\/p>\n<p style=\"text-align:right;font-size:.9em;color:#999999;\">* Target calculation: 3000 + ( 3000 &#8211; 2500 ) = 3500<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FTSE 100 is testing its new support level at 6700. Follow-through above 6800 would indicate respect &mdash; and an advance to the December 1999 high of 6950\/7000*. Rising 13-week Twiggs Money Flow suggests buying pressure. Reversal below 6600 is unlikely, but would warn of a correction to primary support at 6400. * Target calculation: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;European stocks advance&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[57,33],"tags":[1103,1481],"class_list":["post-8725","post","type-post","status-publish","format-standard","hentry","category-stock-markets","category-uk-europe-countries-regions","tag-dow-jones-euro-stoxx-50","tag-ftse-100"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>European stocks advance - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"European stocks advance - the patient investor\" \/>\n<meta property=\"og:description\" content=\"The FTSE 100 is testing its new support level at 6700. Follow-through above 6800 would indicate respect &mdash; and an advance to the December 1999 high of 6950\/7000*. Rising 13-week Twiggs Money Flow suggests buying pressure. Reversal below 6600 is unlikely, but would warn of a correction to primary support at 6400. * Target calculation: &hellip; Continue reading &quot;European stocks advance&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2013-11-12T08:19:18+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/static.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"European stocks advance\",\"datePublished\":\"2013-11-12T08:19:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/\"},\"wordCount\":87,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png\",\"keywords\":[\"Dow Jones Euro Stoxx 50\",\"FTSE 100\"],\"articleSection\":[\"Stock Markets\",\"UK &amp; Europe\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/\",\"name\":\"European stocks advance - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png\",\"datePublished\":\"2013-11-12T08:19:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#primaryimage\",\"url\":\"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png\",\"contentUrl\":\"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"European stocks advance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"European stocks advance - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"European stocks advance - the patient investor","og_description":"The FTSE 100 is testing its new support level at 6700. Follow-through above 6800 would indicate respect &mdash; and an advance to the December 1999 high of 6950\/7000*. Rising 13-week Twiggs Money Flow suggests buying pressure. Reversal below 6600 is unlikely, but would warn of a correction to primary support at 6400. * Target calculation: &hellip; Continue reading \"European stocks advance\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2013-11-12T08:19:18+00:00","og_image":[{"url":"http:\/\/static.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"European stocks advance","datePublished":"2013-11-12T08:19:18+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/"},"wordCount":87,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png","keywords":["Dow Jones Euro Stoxx 50","FTSE 100"],"articleSection":["Stock Markets","UK &amp; Europe"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/","name":"European stocks advance - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png","datePublished":"2013-11-12T08:19:18+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#primaryimage","url":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png","contentUrl":"https:\/\/www.incrediblecharts.com\/images\/2013\/2013-11-12-ftse.png"},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/12\/european-stocks-advance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"European stocks advance"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-2gJ","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":8818,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/12\/03\/dax-leads-the-way\/","url_meta":{"origin":8725,"position":0},"title":"DAX leads the way","author":"ColinTwiggs","date":"December 3, 2013","format":false,"excerpt":"The FTSE 100 continues to test support at 6600. Upward breakout from the recent flag formation would signal an advance to the December 1999 high of 6950\/7000*. Falling 13-week Twiggs Money Flow suggests medium-term selling pressure, but a trough above zero would be a long-term bull signal. Breach of 6600\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"FTSE 100","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-12-03-ftse.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-12-03-ftse.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-12-03-ftse.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":8652,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/10\/22\/european-breakout-2\/","url_meta":{"origin":8725,"position":1},"title":"European breakout","author":"ColinTwiggs","date":"October 22, 2013","format":false,"excerpt":"Dow Jones Euro Stoxx 50 \u2014 representing 50 leading stocks in the Eurozone \u2014 broke long-term resistance at 3000, while the 13-week Twiggs Momentum trough above zero suggests a healthy up-trend. Expect retracement to test the new support level; respect would signal a primary advance, while failure would test 2850,\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"Euro Stoxx 50","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-22-stoxx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-22-stoxx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-22-stoxx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":8798,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/25\/ftse-flags-further-gains\/","url_meta":{"origin":8725,"position":2},"title":"FTSE flags further gains","author":"ColinTwiggs","date":"November 25, 2013","format":false,"excerpt":"Upward breakout from the recent flag formation on the FTSE 100 would signal an advance to the December 1999 high of 6950\/7000*. Rising 13-week Twiggs Money Flow suggests medium-term buying pressure, but the specter of a long-term bearish divergence remains. Expect strong resistance at 7000. Reversal below 6600 is unlikely,\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"FTSE 100","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-25-ftse.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-25-ftse.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-25-ftse.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":8755,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/18\/dax-leads-european-advance\/","url_meta":{"origin":8725,"position":3},"title":"DAX leads European advance","author":"ColinTwiggs","date":"November 18, 2013","format":false,"excerpt":"Germany's DAX broke through resistance at 9000, sharply rising 13-week Twiggs Money Flow signaling strong medium-term buying pressure. Target for the current advance is 9500*. Reversal below 9000 is unlikely, but would warn of a correction to the primary trendline between 8000 and 8500. * Target calculation: 8500 + (\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"DAX","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-18-dax.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-18-dax.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-18-dax.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":8616,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/10\/14\/europe-on-the-rise\/","url_meta":{"origin":8725,"position":4},"title":"Europe on the rise","author":"ColinTwiggs","date":"October 14, 2013","format":false,"excerpt":"Dow Jones Euro Stoxx 50 \u2014 representing 50 leading stocks in the Eurozone \u2014 is advancing strongly, with a 13-week Twiggs Momentum trough above zero suggesting a healthy up-trend. Breakout above 2800 offers a target of 3200*. Reversal below 2850 is unlikely, but would warn of a correction to the\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"Euro Stoxx 50","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-15-stoxx.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-15-stoxx.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-10-15-stoxx.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":8709,"url":"https:\/\/thepatientinvestor.com\/index.php\/2013\/11\/04\/europe-tests-key-resistance-levels\/","url_meta":{"origin":8725,"position":5},"title":"Europe tests key resistance levels","author":"ColinTwiggs","date":"November 4, 2013","format":false,"excerpt":"The monthly chart of the FTSE 100 is testing resistance at the 2007 high of 6750. Rising 13-week Twiggs Money Flow signals buying pressure. Breakout above 6750 would test the 1999\/2000 high at 7000*. Respect of resistance (reversal below 6650) is unlikely, but would warn of a correction to primary\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"FTSE 100","src":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-04-ftse.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-04-ftse.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.incrediblecharts.com\/images\/2013\/2013-11-04-ftse.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/8725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=8725"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/8725\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=8725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=8725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=8725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}